LEO LOEWE, M.D.; SAMUEL CANDEL, M.D., F.A.C.P.; HAROLD B. EIBER, M.D.
Despite the uniformly favorable results following the use of antibiotics in the therapy of subacute bacterial endocarditis due to Streptococcus viridans,1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 the same treatment programs when the enterococcus (Streptococcus fecalis) is the offending organism have mostly met with failure. Although an occasional success has been reported,19, 20, 21, 22 the therapy of enterococcus endocarditis still remains a challenge.
The purpose of this communication is to analyze the factors responsible for the failures and to describe methods which have been adopted in an effort
Learn more about subscription options.
Register Now for a free account.
LOEWE L, CANDEL S, EIBER HB. THERAPY OF SUBACUTE ENTEROCOCCUS (STREPTOCOCCUS FECALIS) ENDOCARDITIS(THERAPY OF SUBACUTE ENTEROCOCCUS (STREPTOCOCCUS FECALIS) ENDOCARDITIS*). Ann Intern Med. 1951;34:717–736. doi: 10.7326/0003-4819-34-3-717
Download citation file:
Published: Ann Intern Med. 1951;34(3):717-736.
Cardiology, Endocarditis, Infectious Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only